CPI

CPI (Centre for Process Innovation) is a British technology and innovation social enterprise covering the agricultural and food technology, energy storage, health technology, materials, and pharmaceutical industry markets, with an emphasis on sustainable solutions and improving healthcare.

CPI helps small and medium enterprises, entrepreneurs and companies to develop, prove, prototype and scale-up new products and processes by providing access to facilities, expertise and networks of public and private funders.Edit Full Business DescriptionAlignment with EIT Food ObjectivesHelp Alignment with EIT Food ObjectivesHow is the organisation directly or indirectly active in or for the Food sector, and how does the organisation align to the objectives of EIT Food.CPI is a world-renowned enabler of innovation, helping to translate innovations into commercial reality. Barriers to translating innovations exist and include access to infrastructure, technical acumen and investment required to scale up. CPI is uniquely
placed to address these barriers and support innovative companies who are attempting to scale technologies that will impact how food is produced.
Through our world-leading facilities, which include CPI’s food-grade facility (certified to FSSC 22000), we work with companies to produce alternative proteins that are looking to complement the existing products in the food value chain. CPI is usually the first point of contact for these companies and we can support them by making their processes more technically efficient, economically viable and ready for commercial production. Our expert staff have experience of scaling up innovations and pass on that knowledge to the early-stage technology developers.

In addition, CPI works with organisations, through our CR&D team,
to source and apply for grant-funding opportunities which will enable process development to be carried out. CPI also has a venture capital and investor engagement arm, through which CPI can make strategic investments into companies looking to impact key markets. Two recent investments were made in the area of alternative proteins whereby CPIE invested in MarraBio
and Qkine.